IMF Person
School of Nursing/College of Science and Health
De Paul University
Chicago, Illinois
IMF Person
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
IMF Person
Jon Fitzpatrick worked with the IMF for several years as a volunteer before joining our team as the Support Group Coordinator. He is excited to turn his passion for helping others into a career. Jon’s interest in working closely with multiple myeloma patients and caregivers was sparked as a…
IMF Person
Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, OH
IMF Person
H. Lee Moffitt Cancer Center
and Research Institute
Tampa, Florida
Page
The International Myeloma Working Group (IMWG) Conference Series: Making Sense of Treatment is a medical education program created by the International Myeloma Foundation (IMF) to bring lively expert discussion of important myeloma treatment issues into the homes and offices of viewers around the…
Page
In this on-demand Webcast of a live symposium in Atlanta, Georgia, expert faculty review optimal care for patients with myeloma, including diagnosis and current and emerging treatment approaches.
To view the activity in its entirety and receive CME credits, …
Page
The following videos, presented by Medscape Oncology, are excerpts from virtual courses designed for certified medical education (CME) credits. Presented by IMF Chairman of the Board Brian G.M. Durie, M.D., these courses discuss the use of proteasome inhibitors in multiple myeloma.
To earn these…
Videos
In this week’s video, Dr. Brian G.M. Durie discusses whether or not small steps in the available treatments for multiple myeloma can be considered progress.
BOTTOM LINE:
All treatment benefits are good, but the “longer the better,” is an important perspective…
Videos
In this week’s video, Dr. Brian G.M. Durie explains how different types of tests for multiple myeloma are used for risk stratification of a patient’s disease.
BOTTOM LINE:
FISH testing is a standard, widely used technique, but DNA testing will most likely be used more…